Appistry has launched the Cancer Genome Analysis Suite, a set of tools for analyzing next-generation sequencing cancer genome data. The suite contains a tool to provide high sensitivity for identifying low-frequency point mutations and difficult to find discrepancies in DNA sequences that are a hallmark of tumor development.
The suite features two of the Broad Institute's tools: the Genome Analysis Toolkit and MuTect for identifying point mutations.